**Abstract**

**Background:** Glucocorticoids, stress hormones released from the adrenal cortex, reduce phobic fear in patients with anxiety disorders. Previous studies have shown that fear-related amygdala activation can be mediated through the visual cortical pathway, which includes the fusiform gyrus, or other pathways. However, it is still unclear, which of the pathways that activate the amygdala is responsible for the pathophysiology of specific phobia and how glucocorticoid treatment alleviates fear processing in these neural networks. In the present study, we aimed to investigate the neural pathway of acute fear-reducing effect of glucocorticoid administration in phobia.

**Methods:** We used functional magnetic resonance imaging to record brain activity in thirty patients with spider phobia, who received either 20 mg of cortisol or a placebo, while they viewed pictures of spiders. We also tested twenty-one healthy participants, who did not receive any medication on the same task. We then performed connectivity analysis to examine the effects of cortisol on the networks involved with processing fear and looked for an association of these networks with phobic symptoms.

**Results:** Cortisol administration reduced the fear of spider pictures and suppressed fear-related amygdala activation. Connectivity analysis revealed that cortisol administration suppressed the aberrant inputs to the amygdala that do not originate from the lingual and fusiform gyri or interactions between the amygdala and fusiform gyrus. We also found the strengths of the aberrant inputs to the amygdala were positively correlated with the severity of spider phobia.

**Conclusions:** The study demonstrates that patients with spider phobia show aberrant functional connectivity of the amygdala when exposed to phobic stimuli. Furthermore, cortisol administration can alleviate this fear-specific neural connectivity.
